Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IHE vs. XPH: which is better?

Bottom line

IHE vs XPH: the short answer

IHE (iShares U.S. Pharmaceuticals ETF) and XPH (State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF) are quite different portfolios: only about 17% of their top holdings (by weight) are shared.

XPH is cheaper at 0.35% vs 0.37% — a difference of $2.00 a year per $10,000 invested.

Over five years, IHE returned +9.1% a year vs +2.8% for XPH.

Updated Nov 19, 2026

IHE vs XPH side by side

IHEXPH
TypeETFETF
Fund familyiSharesSPDR (State Street)
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.37%0.35%
Annual cost per $10k$37$35
10-yr cost on $10k (prospectus)$468$443
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+31.7%+31.6%
5-yr return (annualized)+9.1%+2.8%
10-yr return (annualized)+6.2%+1.9%
Best quarter+17.6%+28.6%
Worst quarter−16.0%−24.3%
Net assets (fund)$1.1B$428.4M
Number of holdings5967
Portfolio turnover29%69%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIHEXPHDifference
2025+31.7%+31.6%+0.1%
2024+8.1%+5.1%+3.0%
2023+1.0%+2.9%−1.9%
2022−4.8%−9.8%+5.0%
2021+12.8%−10.5%+23.3%
2020+13.8%+14.4%−0.6%
2019+15.5%+25.7%−10.2%
2018−7.7%−15.2%+7.5%
2017+10.7%+12.0%−1.4%
2016−11.7%−23.2%+11.5%

Source: Fund prospectus bar charts

Holdings overlap

12 of IHE's top 25 holdings also appear in XPH's top 25.

Shared top holdings
HoldingIHEXPH
Merck & Co., Inc.4.55%1.65%
Elanco Animal Health Incorporated2.81%1.64%
Corcept Therapeutics Incorporated1.90%1.70%
Ligand Pharmaceuticals Incorporated1.45%1.94%
Definium Therapeutics Inc1.39%3.09%
Liquidia Corp1.28%1.86%
Indivior Pharmaceuticals, Inc.1.14%1.64%
Crinetics Pharmaceuticals Inc0.90%1.66%
Edgewise Therapeutics Inc0.70%1.88%
Amneal Pharmaceuticals, Inc.0.68%1.72%
Enliven Therapeutics Inc0.63%2.09%
Veradermics Inc0.56%2.02%

Source: SEC Form N-PORT

IHE top 10

  1. Johnson & Johnson — 22.44%
  2. Eli Lilly And Company — 22.25%
  3. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
  4. Merck & Co., Inc. — 4.55%
  5. Bristol-myers Squibb Company — 4.37%
  6. Royalty Pharma Plc — 4.34%
  7. Viatris Inc. — 4.22%
  8. Pfizer Inc. — 3.96%
  9. Zoetis Inc. — 3.73%
  10. Jazz Pharmaceuticals Public Limited Company — 3.45%

XPH top 10

  1. State Street Global Advisors — 8.58%
  2. Definium Therapeutics Inc — 3.09%
  3. MBX Biosciences Inc — 2.72%
  4. Alumis Inc — 2.14%
  5. AtaiBeckley Inc — 2.13%
  6. Trevi Therapeutics Inc — 2.12%
  7. Enliven Therapeutics Inc — 2.09%
  8. Amylyx Pharmaceuticals Inc — 2.04%
  9. VeraDermics Inc — 2.02%
  10. Ligand Pharmaceuticals Inc — 1.94%

FAQ

What is the difference between IHE and XPH?
IHE (iShares U.S. Pharmaceuticals ETF) and XPH (State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF) are quite different portfolios: only about 17% of their top holdings (by weight) are shared. XPH is cheaper at 0.35% vs 0.37% — a difference of $2.00 a year per $10,000 invested.
Which is cheaper, IHE or XPH?
XPH has the lower expense ratio (0.35%).
Should I own both IHE and XPH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.